chr5-147828151-T-A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000296695.10(SPINK1):c.88-23A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00273 in 1,561,578 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). There are indicators that this mutation may affect the branch point..
Frequency
Consequence
ENST00000296695.10 intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPINK1 | NM_001379610.1 | c.88-23A>T | intron_variant | ENST00000296695.10 | NP_001366539.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPINK1 | ENST00000296695.10 | c.88-23A>T | intron_variant | 1 | NM_001379610.1 | ENSP00000296695 | P1 | |||
SPINK1 | ENST00000510027.2 | c.88-23A>T | intron_variant | 3 | ENSP00000427376 | |||||
SPINK1 | ENST00000505722.1 | upstream_gene_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.00208 AC: 316AN: 152162Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00246 AC: 590AN: 239486Hom.: 1 AF XY: 0.00256 AC XY: 331AN XY: 129490
GnomAD4 exome AF: 0.00280 AC: 3945AN: 1409298Hom.: 8 Cov.: 22 AF XY: 0.00280 AC XY: 1970AN XY: 703776
GnomAD4 genome AF: 0.00208 AC: 316AN: 152280Hom.: 0 Cov.: 32 AF XY: 0.00188 AC XY: 140AN XY: 74472
ClinVar
Submissions by phenotype
Hereditary pancreatitis Benign:4
Benign, criteria provided, single submitter | curation | Sema4, Sema4 | Feb 26, 2020 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 20, 2022 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 31, 2020 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Benign, criteria provided, single submitter | clinical testing | KCCC/NGS Laboratory, Kuwait Cancer Control Center | Jul 07, 2023 | - - |
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Oct 31, 2023 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | May 22, 2017 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Hereditary pancreatitis;C1842402:Tropical pancreatitis Benign:1
Benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | May 23, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at